Dipna Pharmachem, a company in the Pharmaceuticals industry, reported revenue of ₹24 crore and net profit of ₹0.39 crore for the June 2026 quarter.
Dipna Pharmachem (BSE: DPL) closed at ₹3.90 on 20 Nov 2026, down 74.8% over the past year. Its market capitalisation is ₹10 crore and it trades at 4.2 times earnings.
Incorporated in 2011, Dipna Pharmachem Ltd is in the business of Pharmaceutical Trading
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.